CUSIP 59935V107COMMISTQ4 2025
49 filings · latest Dec 23, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Propel Bio Management, LLC | 4.12M | $8.32M |
| 2 | Adage Capital Partners Gp, L.L.C. | 2.81M | $5.68M |
| 3 | Rtw Investments, LP | 2.51M | $5.06M |
| 4 | Marshall Wace, LLP | 1.66M | $3.35M |
| 5 | Two Sigma Investments, LP | 1.51M | $3.06M |
| 6 | Simplify Asset Management Inc. | 1.51M | $3.04M |
| 7 | Jane Street Group, LLC | 1.09M | $2.21M |
| 8 | Pathstone Holdings, LLC | 1.02M | $2.10M |
| 9 |
| 4 | Nov 13, 2025 | Adage Capital Management, L.P. | 13G | 10.0% | 8.66M | SEC |
| 5 | Jul 21, 2025 | Trails Edge Capital Partners, LP | 13G | 9.9% | 8.85M | SEC |
| 6 | Apr 30, 2025 | Integrated Core Strategies (Us) LLC | 13G/A | 11.0% | 322.1K | SEC |
| 7 | Apr 22, 2025 | Blackrock, Inc. | 13G/A | — | — | SEC |
| 8 | Feb 14, 2025 | Rtw Investments, LP | 13G/A | 10.0% | 5.64M | SEC |
| 9 | Feb 5, 2025 | Blackrock, Inc. | 13G/A | 7.6% | 4.05M | SEC |
| 10 | Oct 29, 2024 | Integrated Core Strategies (Us) LLC | 13G/A | 5.1% | 2.74M | SEC |
See the full Schedule 13D/13G history for Milestone Pharmaceuticals In.
Unlock full history| Morgan Stanley |
| 781.9K |
| $1.58M |
| 10 | Lion Point Capital, LP | 755.0K | $1.53M |